Thursday , 26 April 2018


The 7 Most Efficient Canadian Cannabis Producers

munKNEE.com  A Fast & Easy Read of the Latest & Best Financial Articles (Here‘s Why)

Today we have identified seven Canadian cannabis producers based on sale cost and production efficiency.

The original article has been edited here for length (…) and clarity ([ ])

As cannabis has not been produced on this scale until recently, companies have room to develop new ways to produce in a more cost-efficient manner. Companies that can significantly outcompete their peers’ production efficiency could see high profit margins when the recreational market opens up. For reference, the average forward EV/EBITDA multiple for 2019 and 2020 is 16.7x and 7.8x, respectively.

1. Canopy Growth Corp. (TSX:WEED)
Cannabis

As Canada’s largest publicly-traded cannabis company, Canopy Growth operates two producing facilities with ~540,000 sq. ft. and has 5.7M sq. ft. in developing facilities. In addition, the Company owns a variety of diverse brands that include Tweed, Spectrum Cannabis, and Bedrocan. Canopy currently serves ~69,000 patients across Canada.

  • Market Cap: C$5,475.1 Million
  • Forward EV/EBITDA FY2018: N/A
  • Forward EV/EBITDA FY2019: N/M
  • Forward EV/EBITDA FY2020: 23.4x
  • Cash Cost/Gram, Last Reported: C$2.53
  • Annualized Grams Sold/Production Square Foot, Last Reported: 17.2

2. Aurora Cannabis Inc. (TSX:ACB)
Cannabis

Aurora Cannabis is a licensed producer and seller of medical marijuana and cannabis oil under the ACMPR. Aurora sells its products over the phone, online or through its mobile app and offers a delivery service to its customers. Currently, the Company is engaged in the construction of its new 800,000 square foot production facility in Alberta called Aurora Sky. On January 24, Aurora announced the acquisition of CanniMed Therapeutics Inc. (TSX:CMED) for C$1.1 billion.

  • Market Cap: C$4,426.3 Million
  • Forward EV/EBITDA FY2018: N/M
  • Forward EV/EBITDA FY2019: 3.2x
  • Forward EV/EBITDA FY2020: 1.7x
  • Cash Cost/Gram, Last Reported: C$1.74
  • Annualized Grams Sold/Production Square Foot, Last Reported: 48.8

3. Aphria Inc. (TSX:APH)
Cannabis

Aphria is a licensed producer and supplier of medical marijuana under the ACMPR. Aphria’s flagship greenhouse production facility is located on a 169-acre property in Leamington, Ontario. The Company currently produces 9,000kg and plans to expand its production facility to add an additional 90,000kg.

  • Market Cap: C$2,066.3 Million
  • Forward EV/EBITDA FY2018: N/M
  • Forward EV/EBITDA FY2019: N/M
  • Forward EV/EBITDA FY2020: 23.4x
  • Cash Cost/Gram, Last Reported: C$2.13
  • Annualized Grams Sold/Production Square Foot, Last Reported: 15.4

4. MedReleaf Corp. (TSX:LEAF)
Cannabis

MedReleaf is a licensed producer of medical marijuana under the ACMPR. MedReleaf currently produces 7,000 KG/year out of a 55,000 sq. ft. facility in Markham. The Company started to produce 5,600 KG/year out of a 210,000 sq. ft. facility in Bradford in October. The Company plans to expand its Bradford facility to reach 28,000 KG/year from it by August 2018. The Company has partnered with Shoppers Drug Mart to sell medical marijuana.

  • Market Cap: C$1,516.8 Million
  • Forward EV/EBITDA FY2018: N/M
  • Forward EV/EBITDA FY2019: N/M
  • Forward EV/EBITDA FY2020: 27.3x
  • Cash Cost/Gram, Last Reported: C$1.83
  • Annualized Grams Sold/Production Square Foot, Last Reported: 19.1

5. CanniMed Therapeutics Inc. (TSX:CMED)
Cannabis

CanniMed Therapeutics is a Canada-based company that produces pharmaceutical grade cannabis, licensed under the ACMPR to sell up to 7000kg of medical marijuana to patients. The Company offers a range of cannabis-related products that include cannabis oil, dried cannabis, vaporizers and other related accessories. Aurora Cannabis (TSX:ACB) currently owns 95.9% of CanniMed.

  • Market Cap: C$742.0 Million
  • Forward EV/EBITDA FY2018: N/M
  • Forward EV/EBITDA FY2019: N/M
  • Forward EV/EBITDA FY2020: N/A
  • Cash Cost/Gram, Last Reported: C$1.30
  • Annualized Grams Sold/Production Square Foot, Last Reported: 18.8

6. CannTrust Holdings Inc.  (TSX:TRST)
Cannabis

CannTrust is a Canada-based licensed producer of medical cannabis. The Company’s products are sold online and delivered to registered patients. CannTrust’s original 50,000 square foot production facility located in Vaughan, Ontario uses hydroponic technology to produce at an annual capacity of 3,600 KG. Furthermore, CannTrust has set aside a 46-acre property, where it plans to add capacity with a 430,000-square foot expansion.

  • Market Cap: C$578.0 Million
  • Forward EV/EBITDA FY2018: 28.7x
  • Forward EV/EBITDA FY2019: 17.7x
  • Forward EV/EBITDA FY2018: 13.2x
  • Cash Cost/Gram, Last Reported: C$6.18
  • Annualized Grams Sold/Production Square Foot, Last Reported: 75.8

Scroll to very bottom of page & add your comments on this article. We want to share what you have to say!

Related Articles From the munKNEE Vault:

1. 9 Things Cannabis Investors Should Know

Today’s infographic comes to us from Evolve ETFs, and it shows what investors should know as the legal cannabis sector comes out of the dark.

2. These 4 Marijuana Stocks Expected To Generate Significant EBITDA Growth Over Coming Year

As recreational legalization in Canada approaches this summer, the 4 marijuana stocks on our list today have plans to meet the upcoming demand. If the marijuana sector continues its rally, these stocks…are expected to generate significant EBITDA growth over the coming year.

3. Marijuana/Cannabis Stocks: Analysts Say These 5 Companies Have the Potential to More Than Double in Price This Year

To take advantage of another potential upswing in the market, we have selected 5 cannabis companies, which analysts believe are undervalued. The Canadian marijuana stocks on our list today currently have 100% upside on average according to analysts, indicating that these stocks could post strong returns in the near-term.

4. 4 Canadian Marijuana Stocks with Notable Expected EBITDA Growth

As recreational legalization of marijuana in Canada approaches this summer, these companies have plans to meet the upcoming demand. If marijuana continues its rally, the Canadian marijuana stocks on our list could see strong returns in both the short and long term.

5. Aurora Cannabis Inc. vs. Canopy Growth Corp.: Which Marijuana Stock is More Attractive?

The top spot in the Canadian cannabis industry belongs to Canopy Growth Corp. but some competitors, such as Aurora Cannabis Inc., have the scope, scale, and differentiation to take on the market leader. Of these two which stock is more attractive?

6. Aurora Cannabis Inc. vs. Aphria Inc.: Which One Is A Better Buy?

Today we will be comparing the current and future prospects of Aurora Cannabis and Aphria Inc. – the only two companies with the scope, scale, and differentiation to take on Canopy Growth.

7. These 4 Medical Cannabis Stocks Expected to Generate Positive EPS

Due to the early stages of the cannabis industry and its growth prospects, investors have not expected cannabis companies to generate positive earnings. Instead they have valued the stocks primarily on hope for a lucrative future. That being said, however, we have identified 4 Canadian cannabis stocks that are expected to generate positive earnings in the next 12 months. If they live up to their earnings expectations, it could begin a time when investors look for companies with sustainable growth prospects, as opposed to those that are expected to have the highest short-term revenue growth.

8. Marijuana Stocks vs. Battery Stocks vs. Tech Stocks: Which Will See the Highest ROI?

Being able to sell products at a high margin is a good sign of efficiency. Doing so leaves more cash to dedicate to other expenses and service debt obligations. Identifying undervalued companies with strong gross margins in the young marijuana industry is important, given the upcoming Canadian legalization of marijuana for recreational purposes in 2018. Today we have identified 4 Canadian marijuana stocks that have underperformed their peers despite healthy gross margins.

10. These 5 Medical Marijuana Stocks Have the Greatest Upside Potential

Investing in marijuana-related stocks is a high-risk, high-reward game due to all the uncertainties surrounding the legalization of the drug. Companies that do succeed, however, have potential to bring large capital gains. That being said we have identified five Canadian marijuana stocks with the biggest upside potential, according to consensus analyst price targets.

11. 5 Marijuana Stocks With Gross Margins Well Above Their Industry Peers

Identifying companies with high gross margins in the young marijuana industry is important because operating costs are likely to decrease as the industry matures, leaving these companies with high earnings potential. Today we have identified five Canadian marijuana stocks with gross margins well above their industry peers.

12. Is One of These 5 Junior Marijuana Stocks Ripe For Acquisition?

The search is now on for the next junior marijuana stock that is ripe for acquisition. Will it be one of the 5 we’ve identified based upon their high revenue growth profiles?

For all the latest – and best – financial articles sign up (in the top right corner) for your free bi-weekly Market Intelligence Report newsletter (see sample here) or visit our Facebook page.

Leave a Reply

Your email address will not be published. Required fields are marked *